PBE icon

Invesco Biotechnology & Genome ETF
PBE

Overview Fund Activity

96 hedge funds and large institutions have $88M invested in Invesco Biotechnology & Genome ETF in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 31 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
-6
Holders Change %
-5.88%
% of All Funds
1.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
20
Reduced
31
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
$2.37M
2
Citadel Advisors
Citadel Advisors
Florida
$569K
3
GKWIM
Gerber Kawasaki Wealth & Investment Management
California
$14.9M
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
$4.1M
5
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
$1.73M

Top Sellers

1
CW
CreativeOne Wealth
Kansas
$1.49M
2
Pathstone Holdings
Pathstone Holdings
New Jersey
$333K
3
Jane Street
Jane Street
New York
$0
4
WBG
Wharton Business Group
Pennsylvania
$0
5
UBS Group
UBS Group
Switzerland
$5.03M
Name Holding Trade Value Shares
Change 		Shares
Change %
CIC
101
Carnegie Investment Counsel
Ohio
– -$204K -2,916 Closed
SWP
102
Stratos Wealth Partners
Ohio
– -$203K -2,907 Closed
C
103
Covestor
United Kingdom
– -$47K -670 Closed
HR
104
Howe & Rusling
New York
– -$30.7K -440 Closed
BTI
105
Blue Trust Inc
Georgia
– -$19.7K -304 Closed
BWP
106
Baldwin Wealth Partners
Massachusetts
– -$3.49K -50 Closed
1 2 3 4
5